Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
87.40    2.10 (2.46%)
Bid:
87.00
Ask:
88.90
Spread: 1.90 (2.184%)
Market Cap: £367.39m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Trading Update

15 Jun 2017 07:00

RNS Number : 1190I
PZ CUSSONS PLC
15 June 2017
 

15 June 2017

PZ Cussons Plc

(the "Group")

 

TRADING UPDATE

 

PZ Cussons Plc, a leading international consumer products group, today issues the following trading update in respect of the year ended 31 May 2017.

Overview

 

The board is pleased to announce that the overall performance of the Group has been in line with expectations.

 

The Group's balance sheet remains strong with cash generation for the period also in line with expectations.

 

Europe

 

In the UK, performance in the washing and bathing division has been robust with renovation and innovation continuing to drive good performance across Imperial Leather, Carex and Original Source despite competitive market conditions. The Imperial Leather range has been completely relaunched during the year and successful product launches have taken place under the Carex and Original Source brands.

 

In the beauty division, Sanctuary, St Tropez, Charles Worthington and Fudge have all performed well. The relaunch of the Sanctuary brand has now been completed with a new product range and a more premium look and feel. The new sub-brand, Being by Sanctuary, is now available in store and online and is targeting younger consumers with a range of 46 products. New product launches under the St Tropez brand include a new-to-market self-tan face mask.

 

Performance in the smaller markets of Poland and Greece has been in line with expectations.

 

Asia

 

In Australia, new product launches, range extensions and margin improvement initiatives have continued to improve the profitability of the business despite ongoing challenging trading conditions and all brands are performing well.

 

In Indonesia, good growth has continued across the brand portfolio with Cussons Baby strengthening its market leading position. Successful product launches in the year include the relaunch of the Cussons Kids range together with a new range of Imperial Leather products.

 

Performance in the smaller markets of Thailand and the Middle East has been in line with expectations.

 

Africa

 

In Nigeria, whilst liquidity has improved during the second half, availability of US dollars at the interbank rate remains low resulting in the need to continue accessing the secondary market.

 

All business units across Personal Care, Home Care, Electricals and Food & Nutrition have continued to trade relatively well in an environment where the consumer is under significant inflationary pressure. The Group's diverse product range with product offerings at all price points has ensured that market shares are held or grown across the brand portfolio.

 

Performance in the smaller markets of Ghana and Kenya has been in line with expectations.

 

Outlook

 

The strength and agility of the Group's brand portfolio is underpinning solid performance in all regions and new product launches are performing well.

 

Tight control of costs together with further margin improvement initiatives are successfully countering ongoing raw material and exchange rate volatility.

 

The Group's balance sheet remains strong and well placed to pursue new opportunities as they arise.

 

Final Results

 

Final results for the year ended 31 May 2017 will be announced on Tuesday 25 July 2017.

 

- ENDS -

For further information contact:

 

PZ Cussons Plc

Brandon Leigh - Chief Financial Officer

 

Tel: 0161 435 1236

Instinctif

Tim Linacre / Guy Scarborough

Tel: 020 7457 2020

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGGUQGQUPMGQC
Date   Source Headline
20th May 20264:49 pmRNSDirector/PDMR Shareholding
21st Apr 20262:49 pmRNSDirector/PDMR Shareholding
14th Apr 20268:43 amRNSDirector/PDMR Shareholding
10th Apr 20264:01 pmRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSQ3 TRADING UPDATE
19th Mar 20268:59 amRNSDirector/PDMR Shareholding
3rd Mar 20264:27 pmRNSDirector/PDMR Shareholding
19th Feb 202611:04 amRNSDirector/PDMR Shareholding
13th Feb 20263:32 pmRNSDirector/PDMR Shareholding
13th Feb 20262:21 pmRNSDirector/PDMR Shareholding
11th Feb 20267:01 amRNSCapital Markets Event
11th Feb 20267:00 amRNSInterim Results
22nd Jan 20263:00 pmRNSDirectorate change
20th Jan 20264:39 pmRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSDirectorate change
22nd Dec 20257:00 amRNSDirectorate change
18th Dec 20255:29 pmRNSDirector/PDMR Shareholding
18th Dec 20255:29 pmRNSDirector/PDMR Shareholding
15th Dec 20254:27 pmRNSHolding(s) in Company
11th Dec 20257:00 amRNSConclusion of Strategic Review of Africa
2nd Dec 20252:42 pmRNSDirector/PDMR Shareholding
28th Nov 20253:25 pmRNSDirector/PDMR Shareholding
20th Nov 20254:23 pmRNSResult of AGM
20th Nov 20257:00 amRNSAGM Trading Statement
19th Nov 20255:57 pmRNSDirector/PDMR Shareholding
21st Oct 20255:07 pmRNSDirector/PDMR Shareholding
1st Oct 20254:20 pmRNSDirector/PDMR Shareholding
1st Oct 20254:16 pmRNSDirector/PDMR Shareholding
29th Sep 20257:00 amRNSDirectorate Change
25th Sep 202512:06 pmRNSPublication of Annual Report and Notice of AGM
24th Sep 20253:56 pmRNSDirector/PDMR Shareholding
19th Sep 20255:03 pmRNSDirector/PDMR Shareholding
17th Sep 20257:00 amRNSFinal Results
20th Aug 20259:16 amRNSDirector/PDMR Shareholding
21st Jul 20255:07 pmRNSDirector/PDMR Shareholding
26th Jun 20257:00 amRNSUpdate on St. Tropez
19th Jun 20254:47 pmRNSDirector/PDMR Shareholding
18th Jun 20257:00 amRNSSale of Joint Venture and Trading Update
21st May 20254:49 pmRNSDirector/PDMR Shareholding
7th May 20253:29 pmRNSDirector Declaration
23rd Apr 20254:32 pmRNSDirector/PDMR Shareholding
10th Apr 20255:06 pmRNSDirector/PDMR Shareholding
19th Mar 20254:37 pmRNSDirector/PDMR Shareholding
19th Feb 202511:38 amRNSDirector/PDMR Shareholding
11th Feb 20257:00 amRNSInterim Results
21st Jan 202511:43 amRNSDirector/PDMR Shareholding
19th Dec 20244:24 pmRNSDirector/PDMR Shareholding
6th Dec 20243:42 pmRNSDirector/PDMR Shareholding
21st Nov 20245:03 pmRNSResult of AGM
21st Nov 20247:00 amRNSAGM Trading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.